These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6206446)

  • 21. Substance P modulation of the mesolimbic dopamine system.
    Kalivas P
    Prog Clin Biol Res; 1985; 192():403-8. PubMed ID: 2417255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: cross-validation using in vivo voltammetry and microdialysis.
    Blaha CD; Coury A; Fibiger HC; Phillips AG
    Neuroscience; 1990; 34(3):699-705. PubMed ID: 2352647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat.
    Delfs JM; Schreiber L; Kelley AE
    J Neurosci; 1990 Jan; 10(1):303-10. PubMed ID: 2299396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic lead exposure differentially affects dopamine transport in rat striatum and nucleus accumbens.
    Missale C; Battaini F; Govoni S; Castelletti L; Spano PF; Trabucchi M
    Toxicology; 1984 Oct; 33(1):81-90. PubMed ID: 6495347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing.
    Kalivas PW; Nemeroff CB; Prange AJ
    Neuroscience; 1984 Apr; 11(4):919-30. PubMed ID: 6738859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex.
    Abercrombie ED; Keefe KA; DiFrischia DS; Zigmond MJ
    J Neurochem; 1989 May; 52(5):1655-8. PubMed ID: 2709017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phencyclidine (PCP) injected in the nucleus accumbens increases extracellular dopamine and serotonin as measured by microdialysis.
    Hernandez L; Auerbach S; Hoebel BG
    Life Sci; 1988; 42(18):1713-23. PubMed ID: 2452334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study.
    Moghaddam B; Bunney BS
    J Neurochem; 1990 May; 54(5):1755-60. PubMed ID: 1969939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of serotonin involvement in the effect of morphine on dopamine metabolism in the rat nucleus accumbens but not in the striatum.
    Spampinato U; Invernizzi R; Samanin R
    Pharmacol Res Commun; 1984 May; 16(5):519-23. PubMed ID: 6234602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment.
    Ichikawa J; Meltzer HY
    Brain Res; 1990 Jan; 507(1):138-42. PubMed ID: 2302571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats.
    Dreher JK; Jackson DM
    Brain Res; 1989 May; 487(2):267-77. PubMed ID: 2525062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of cholecystokinin octapeptide-stimulated endogenous dopamine release from rat nucleus accumbens in vitro.
    Marshall FH; Barnes S; Pinnock RD; Hughes J
    Br J Pharmacol; 1990 Apr; 99(4):845-8. PubMed ID: 2361176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of pretreatment with amphetamine on the interaction between amphetamine and dopamine neurons in the nucleus accumbens.
    Kolta MG; Shreve P; Uretsky NJ
    Neuropharmacology; 1989 Jan; 28(1):9-14. PubMed ID: 2927583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The C-terminal fragment of substance P enhances dopamine release in nucleus accumbens but not in neostriatum in freely moving rats.
    Boix F; Huston JP; Schwarting RK
    Brain Res; 1992 Oct; 592(1-2):181-6. PubMed ID: 1280516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of the presynaptic receptors in the control of dopamine synthesis in the striate complex and nucleus accumbens].
    Palarea MD; Castro R; Arévalo RM; Rodríguez-Díaz M
    Rev Esp Fisiol; 1986 Mar; 42(1):71-5. PubMed ID: 3715157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substrain differences of age-related changes in in vivo dopamine synthesis in the striatum and nucleus accumbens of the rat brain.
    Watanabe H
    J Pharmacobiodyn; 1987 Jul; 10(7):317-20. PubMed ID: 3694425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine release in n. accumbens and striatum by clozapine: simultaneous monitoring by in vivo electrochemistry.
    Huff RM; Adams RN
    Neuropharmacology; 1980 Jun; 19(6):587-90. PubMed ID: 7402448
    [No Abstract]   [Full Text] [Related]  

  • 39. Protein kinase C mediates the stimulation by somatostatin of dopamine synthesis in the rat striatum and nucleus accumbens.
    Chowdhury M; Steardo L; Fillenz M
    Neurosci Lett; 1987 Nov; 82(2):196-200. PubMed ID: 2892160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional recovery after destruction of dopamine systems in the nucleus accumbens of rats. I. Behavioral and biochemical studies.
    Wolterink G; Van Zanten E; Kamsteeg H; Radhakishun FS; Van Ree JM
    Brain Res; 1990 Jan; 507(1):92-100. PubMed ID: 2105824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.